28808-26-6Relevant articles and documents
Preparation of (R)-3-hydroxy-n-methylpiperidine, a synthetic key intermediate of (R)-mepenzolate, based on the lipase-catalyzed resolution of the racemic form
Yamashita, Yasunobu,Hanaya, Kengo,Shoji, Mitsuru,Sugai, Takeshi
, p. 370 - 379 (2019/05/21)
In this study, a two-step method for the gram-scale synthesis of (R)-3-hydroxy-N-methylpiperidine in 97.8% enantiomeric excess (ee) is reported. The key chiral synthetic intermediate of (R)-mepenzolate was formed in 22% yield over two steps using a commer
QUATERNARY AMMONIUM SALTS AS M3 ANTAGONISTS
-
Page/Page column 39, (2008/06/13)
Compounds of formula (I), in salt or zwitterionic form, wherein J, L, M, R1, R2, R3, R4 and R5 have the meanings as indicated in the specification, are useful for treating conditions that are mediated by the muscarinic M3 receptor. Pharmaceutical compositions that contain the compounds and a process for preparing the compounds are also described.
Ring expansion - Formation of optically active 3-hydroxypiperidines from pyrrolidinemethanol derivatives
Cossy, Janine,Dumas, Cecile,Gomez Pardo, Domingo
, p. 1693 - 1699 (2007/10/03)
Treatment of pyrrolidinemethanol derivatives (-)-1, (-)-6, (-)7, 8, (- )-9, (+)-10, (-)-11, and (-)-21 with trifluoroacetic anhydride and then with Et3N afforded, after hydrolysis of the trifluoroacetyl group with NaOH, the optically active -hy